【障がい者採用：契約社員】リスキリングプログラム（最長2年）/神戸本社 at Eli Lilly and Company

Kobe, Hyogo, Japan

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Hold a disability certificate (障がい者手帳をお持ちの方)
High school graduate or above (高卒以上)
At least 1 year of work experience (実務経験が1年以上ある方)
For general clerical position: Experience operating Word and Excel (ワード、エクセルの操作経験要)
Submit resume, work history, disability details, and accommodation documents (履歴書・職務歴書・障害の内容・必要な配慮が確認できる書類)
May require submission of doctor's opinion (主治医の意見書)

Responsibilities

Participate in the reskilling program (max 2 years) to gain skills for future career (リスキリングプログラム)
Provide support for HR talent acquisition and development tasks (人事部門における人材採用・人材開発関連業務のサポート業務)
Perform general clerical work (一般事務)
Develop foundational knowledge in recruitment and talent development
Enhance office skills including data processing and Excel (基礎的なデータやエクセルなどの事務処理能力)
Build problem-solving skills and communication abilities through various tasks (問題解決力、他者とのコミュニケーション能力)

Skills

Excel

Word

Microsoft Office

Data Processing

HR Administration

Recruitment Support

Talent Development

Problem Solving

Communication

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free